Skip to main content

solanezumab

solanezumab: 2 clinical trials tracked.

solanezumab evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about solanezumab, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 0 study sponsors

Related indications

Dementia

Study sponsors

No additional listed-company sponsor is linked.

Clinical Trial Registry Records (2)

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study)

NCT02008357Registry updated 2026-08-21·Phase 3
Completed

Primary endpoint: Change From Baseline of the Preclinical Alzheimer Cognitive Composite (PACC) Score

InterventionalRandomizedquadruple1,169 enrolledStarted 2014-02Completion 2023-0650 sites · United StatesEli Lilly and Company

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease

NCT01760005Registry updated 2026-07-27·Phase 2/Phase 3
Active, not recruiting

Primary endpoint: Assess cognitive efficacy in individuals with mutations causing dominantly inherited AD as measured by the change from baseline in the DIAN-Multivariate Cognitive Endpoint (DIAN-MCE)

InterventionalRandomizedquadruple490 targetStarted 2012-12Completion 2028-0738 sites · Argentina, Australia, Brazil, Canada…Washington University School of Medicine